IL6 and attention deficit-hyperactivity disorder: A systematic review further concluded that maternal inflammatory markers, including IL-6 and TNF-α, lack sufficient specificity and sensitivity (AUC <0.8) for clinical use in ADHD diagnosis or risk prediction [81].